1.03 USD
-0.01 (-0.96%)
We assign a fundamental rating of 2 out of 10 to COCP. COCP was compared to 190 industry peers in the Pharmaceuticals industry. While COCP has a great health rating, there are worries on its profitability. COCP is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year COCP has reported negative net income.
- In the past year COCP has reported a negative cash flow from operations.
- COCP had negative earnings in each of the past 5 years.
- In the past 5 years COCP always reported negative operating cash flow.
1.2 Ratios
- COCP has a worse Return On Assets (-92.58%) than 76.84% of its industry peers.
- Looking at the Return On Equity, with a value of -126.11%, COCP is doing worse than 66.32% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -92.58% | ||
| ROE | -126.11% | ||
| ROIC | N/A |
ROA(3y)-95.52%
ROA(5y)-64.44%
ROE(3y)-118.44%
ROE(5y)-78.4%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for COCP so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- COCP has about the same amout of shares outstanding than it did 1 year ago.
- The number of shares outstanding for COCP has been increased compared to 5 years ago.
- There is no outstanding debt for COCP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- Based on the Altman-Z score of -44.70, we must say that COCP is in the distress zone and has some risk of bankruptcy.
- COCP has a Altman-Z score of -44.70. This is amonst the worse of the industry: COCP underperforms 92.63% of its industry peers.
- COCP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -44.7 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- COCP has a Current Ratio of 5.78. This indicates that COCP is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 5.78, COCP is in the better half of the industry, outperforming 67.37% of the companies in the same industry.
- A Quick Ratio of 5.78 indicates that COCP has no problem at all paying its short term obligations.
- COCP has a Quick ratio of 5.78. This is in the better half of the industry: COCP outperforms 68.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.78 | ||
| Quick Ratio | 5.78 |
3. Growth
3.1 Past
- COCP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.19%, which is quite impressive.
EPS 1Y (TTM)49.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- COCP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.61% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y53.13%
EPS Next 2Y23.86%
EPS Next 3Y12.61%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- COCP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year COCP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as COCP's earnings are expected to grow with 12.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.86%
EPS Next 3Y12.61%
5. Dividend
5.1 Amount
- COCP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
COCRYSTAL PHARMA INC / COCP FAQ
Can you provide the ChartMill fundamental rating for COCRYSTAL PHARMA INC?
ChartMill assigns a fundamental rating of 2 / 10 to COCP.
What is the valuation status for COCP stock?
ChartMill assigns a valuation rating of 0 / 10 to COCRYSTAL PHARMA INC (COCP). This can be considered as Overvalued.
How profitable is COCRYSTAL PHARMA INC (COCP) stock?
COCRYSTAL PHARMA INC (COCP) has a profitability rating of 0 / 10.
What is the earnings growth outlook for COCRYSTAL PHARMA INC?
The Earnings per Share (EPS) of COCRYSTAL PHARMA INC (COCP) is expected to grow by 53.13% in the next year.